Healthcare interventions improving and reducing quality of life in children at the end of life: a systematic review.
Journal
Pediatric research
ISSN: 1530-0447
Titre abrégé: Pediatr Res
Pays: United States
ID NLM: 0100714
Informations de publication
Date de publication:
04 2021
04 2021
Historique:
received:
01
04
2020
accepted:
15
06
2020
pubmed:
10
7
2020
medline:
8
1
2022
entrez:
10
7
2020
Statut:
ppublish
Résumé
Children with serious illness suffer from symptoms at the end of life that often fail to be relieved. An overview is required of healthcare interventions improving and decreasing quality of life (QOL) for children with serious illness at the end of life. A systematic review was performed in five databases, January 2000 to July 2018 without language limit. Reviewers selected quantitative studies with a healthcare intervention, for example, medication or treatment, and QOL outcomes or QOL-related measures, for example, symptoms, for children aged 1-17 years with serious illness. One author assessed outcomes with the QualSyst and GRADE (Grades of Recommendation, Assessment, Development, and Evaluation) Framework; two authors checked a 25% sample. QOL improvement or reduction was categorized. Thirty-six studies met the eligibility criteria studying 20 unique interventions. Designs included 1 randomized controlled trial, 1 cross-sectional study, and 34 cohort studies. Patient-reported symptom monitoring increased QOL significantly in cancer patients in a randomized controlled trial. Dexmedetomidine, methadone, ventilation, pleurodesis, and palliative care were significantly associated with improved QOL, and chemotherapy, stem cell transplant, and hospitalization with reduced QOL, in cohort studies. Use of patient-controlled symptom feedback, multidisciplinary palliative care teams with full-time practical support, inhalation therapy, and off-label sedative medication may improve QOL. Curative therapy may reduce QOL. QOL for children at the end of life may be improved with patient-controlled symptom feedback, multidisciplinary palliative care teams with full-time practical support, inhalation therapy, and off-label sedative medication. QOL for children at the end of life may be reduced with therapy with a curative intent, such as curative chemotherapy or stem cell transplant. A comprehensive overview of current evidence to elevate currently often-failing QOL management for children at the end of life. New paradigm-level indicators for appropriate and inappropriate QOL management in children at the end of life. New hypotheses for future research, guided by the current knowledge within the field. Various healthcare interventions (as described above) could or might be employed as tools to provide relief in QOL management for children with serious illness, such as cancer, at the end of life, and therefore could be discussed in pediatrician end-of-life training to limit the often-failed QOL management in this population, cave the one-size-fits-all approach for individual cases. Multidisciplinary team efforts and 24/7 presence, especially practical support for parents, might characterize effective palliative care team interventions for children with serious illness at the end of life, suggesting a co-regulating link between well-being of the child partly to that of the parents Hypothesis-oriented research is needed, especially for children with nonmalignant disorders, such as genetic or neurological disorders at the end of life, as well as QOL outcomes for intervention research and psychosocial or spiritual outcomes.
Sections du résumé
BACKGROUND
Children with serious illness suffer from symptoms at the end of life that often fail to be relieved. An overview is required of healthcare interventions improving and decreasing quality of life (QOL) for children with serious illness at the end of life.
METHODS
A systematic review was performed in five databases, January 2000 to July 2018 without language limit. Reviewers selected quantitative studies with a healthcare intervention, for example, medication or treatment, and QOL outcomes or QOL-related measures, for example, symptoms, for children aged 1-17 years with serious illness. One author assessed outcomes with the QualSyst and GRADE (Grades of Recommendation, Assessment, Development, and Evaluation) Framework; two authors checked a 25% sample. QOL improvement or reduction was categorized.
RESULTS
Thirty-six studies met the eligibility criteria studying 20 unique interventions. Designs included 1 randomized controlled trial, 1 cross-sectional study, and 34 cohort studies. Patient-reported symptom monitoring increased QOL significantly in cancer patients in a randomized controlled trial. Dexmedetomidine, methadone, ventilation, pleurodesis, and palliative care were significantly associated with improved QOL, and chemotherapy, stem cell transplant, and hospitalization with reduced QOL, in cohort studies.
CONCLUSIONS
Use of patient-controlled symptom feedback, multidisciplinary palliative care teams with full-time practical support, inhalation therapy, and off-label sedative medication may improve QOL. Curative therapy may reduce QOL.
IMPACT
QOL for children at the end of life may be improved with patient-controlled symptom feedback, multidisciplinary palliative care teams with full-time practical support, inhalation therapy, and off-label sedative medication. QOL for children at the end of life may be reduced with therapy with a curative intent, such as curative chemotherapy or stem cell transplant. A comprehensive overview of current evidence to elevate currently often-failing QOL management for children at the end of life. New paradigm-level indicators for appropriate and inappropriate QOL management in children at the end of life. New hypotheses for future research, guided by the current knowledge within the field. Various healthcare interventions (as described above) could or might be employed as tools to provide relief in QOL management for children with serious illness, such as cancer, at the end of life, and therefore could be discussed in pediatrician end-of-life training to limit the often-failed QOL management in this population, cave the one-size-fits-all approach for individual cases. Multidisciplinary team efforts and 24/7 presence, especially practical support for parents, might characterize effective palliative care team interventions for children with serious illness at the end of life, suggesting a co-regulating link between well-being of the child partly to that of the parents Hypothesis-oriented research is needed, especially for children with nonmalignant disorders, such as genetic or neurological disorders at the end of life, as well as QOL outcomes for intervention research and psychosocial or spiritual outcomes.
Identifiants
pubmed: 32645707
doi: 10.1038/s41390-020-1036-x
pii: 10.1038/s41390-020-1036-x
doi:
Types de publication
Research Support, Non-U.S. Gov't
Systematic Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
1065-1077Références
Håkanson, C. et al. Place of death of children with complex chronic conditions: cross-national study of 11 countries. Eur. J. Pediatr. 176, 327–335 (2017).
pubmed: 28070671
INSPQ. Soins Palliatifs de Fin de Vie Au Québec: Définition et Mesure d’indicateurs, Vol. 53 (INSPQ, 2006).
Johnston, E. E. et al. Disparities in the intensity of end-of-life care for children with cancer. Pediatrics 140, e20170671 (2017).
pubmed: 28963112
Tang, S. T. et al. Pediatric end-of-life care for Taiwanese children who died as a result of cancer from 2001 through 2006. J. Clin. Oncol. 29, 890–894 (2011).
Kassam, A. et al. Predictors of and trends in high-intensity end-of-life care among children with cancer: a population-based study using health services data. J. Clin. Oncol. 35, 236–242 (2017).
pubmed: 28056201
Park, J. D. et al. Trends in the aggressiveness of end-of-life care for Korean pediatric cancer patients who died in 2007-2010. PLoS ONE 9, 1–5 (2014).
Cohen, J. & Deliens L. A Public Health Perspective on End of Life Care (Oxford Univ. Press, Oxford, 2012).
Hinds, P., Pritchard, M. & Harper, J. End-of-life research as a priority for pediatric oncology. J. Pediatr. Oncol. Nurs. 21, 175–179 (2004).
pubmed: 15296049
Brock, K., Mark, M., Thienprayoon, R. & Ullrich, C. in Palliative Care in Pediatric Oncology (eds Wolfe, J., Jones, B. L., Kreicbergs, U. & Jankovic, M.) 287–314 (Springer, 2018).
Goldman, A., Hain, R. & Liben, S. Oxford Textbook of Palliative Care for Children (Oxford University Press, 2012).
Piette, V. & et al. Influence of health interventions on quality of life in seriously ill children at the end of life: a systematic review. Syst. Rev. 8, 1–8 (2019).
Rosenberg, A. R. & Wolfe, J. Approaching the third decade of paediatric palliative oncology investigation: historical progress and future directions. Lancet Child Adolesc. Health 1, 56–67 (2017).
pubmed: 29333484
pmcid: 5764167
McGowan, J. et al. PRESS peer review of electronic search strategies: 2015 guideline statement. J. Clin. Epidemiol. 75, 40–46 (2016).
pubmed: 27005575
Drake, R. & Chang, E. Palliative Care of Pediatric Populations. Textbook of Palliative Care 1209–1224 (2019).
Feudtner, C., Feinstein, J. A., Zhong, W., Hall, M. & Dai, D. Pediatric complex chronic conditions classification system version 2: Updated for ICD-10 and complex medical technology dependence and transplantation. BMC Pediatr. 14, 1–7 (2014).
WHO. International Classification of Health Interventions (ICHI) (eds MacLeod, R. D. & Van den Block, L.) (WHO, 2012).
Kmet, L. M., Lee, R. C. & Cook, L. S. Standard Quality Assessment Criteria for Evaluating Primary Research Papers from a Variety of Fields (Alberta Heritage Foundation for Medical Research, 2004).
Balshem, H. et al. GRADE guidelines: 3. Raring the qualty of evidence. J. Clin. Epidemiol. 64, 401–406 (2011).
pubmed: 21208779
Wolfe, J. et al. Improving the care of children with advanced cancer by using an electronic patient-reported feedback intervention: results from the PediQUEST randomized controlled trial. J. Clin. Oncol. 32, 1119–1127 (2014).
pubmed: 24616307
pmcid: 3970170
Korzeniewska-Eksterowicz, A. Palliative sedation at home for terminally ill children with cancer. J. Pain Symptom Manage. 48, 968–974 (2014).
pubmed: 24751437
Schindera, C. et al. Predictors of symptoms and site of death in pediatric palliative patients with cancer at end of life. Am. J. Hosp. Palliat. Med. 31, 548–552 (2014).
Brook, L., Vickers, J. & Pizer, B. Home platelet transfusion in pediatric oncology terminal care. Med. Pediatr. Oncol. 40, 249–251 (2003).
pubmed: 12555255
Gans, D. et al. Impact of a pediatric palliative care program on the caregiver experience. J. Hosp. Palliat. Nurs. 17, 559–565 (2015).
Madden, K., Mills, S. & Dibaj, S. Methadone as the initial long-acting opioid in children with advanced cancer. J. Palliat. Med. 21, 1317–1321 (2018).
pubmed: 29664690
Groh, G. Specialized home palliative care for adults and children: differences and similarities. J. Palliat. Med. 17, 803–810 (2014).
pubmed: 24926957
pmcid: 4082352
Groh, G. Specialized pediatric palliative home care: a prospective evaluation. J. Palliat. Med. 16, 1588–1594 (2013).
pubmed: 24168349
pmcid: 3868293
Vollenbroich, R. et al. Effectiveness of a pediatric palliative home care team as experienced by parents and health care professionals. J. Palliat. Med. 15, 294–300 (2012).
pubmed: 22216782
Kuhlen, M., Schlote, A., Borkhardt, A. & Janen, G. Häusliche Palliativversorgung von Kindern: Eine Meinungsumfrage bei verwaisten Eltern nach unheilbarer onkologischer Erkrankung. Klin. Padiatr. 226, 182–187 (2014).
pubmed: 24819389
Hoffer, F. A. et al. Pleurodesis for effusions in pediatric oncology patients at end of life. Pediatr. Radiol. 37, 269–273 (2007).
pubmed: 17203294
Chong, P. H., De Castro Molina, J. A., Teo, K. & Tan, W. S. Paediatric palliative care improves patient outcomes and reduces healthcare costs: evaluation of a home-based program. BMC Palliat. Care 17, 1–8 (2018).
Friedrichsdorf, S. J. et al. Improved quality of life at end of life related to home-based palliative care in children with cancer. J. Palliat. Med. 18, 143–150 (2015).
pubmed: 25401507
Thrane, S. E., Maurer, S. H., Cohen, S. M., May, C. & Sereika, S. M. Pediatric palliative care: a five-year retrospective chart review study. J. Palliat. Med. 20, 1104–1111 (2017).
pubmed: 28586256
pmcid: 5647500
Hooke, M. C. et al. Propofol use in pediatric patients with severe cancer pain at the end of life. J. Pediatr. Oncol. Nurs. 24, 29–34 (2007).
pubmed: 17185399
Hohl, C. M. et al. Methotrimeprazine for the management of end-of-life symptoms in infants and children. J. Palliat. Care 29, 178–185 (2013).
pubmed: 24380217
Rapoport, A., Shaheed, J., Newman, C., Rugg, M. & Steele, R. Parental perceptions of forgoing artificial nutrition and hydration during end-of-life care. Pediatrics 131, 861–869 (2013).
pubmed: 23569099
Taylor, M., Jakacki, R., May, C., Howrie, D. & Maurer, S. Ketamine PCA for treatment of end-of-life neuropathic pain in pediatrics. Am. J. Hosp. Palliat. Med. 32, 841–848 (2015).
Burns, J., Jackson, K., Sheehy, K. A., Finkel, J. C. & Quezado, Z. M. The use of dexmedetomidine in pediatric palliative care: a preliminary study. J. Palliat. Med. 20, 779–783 (2017).
pubmed: 28186850
Postovsky, S., Moaed, B., Krivoy, E., Ofir, R. & Ben Arush, M. W. Practice of palliative sedation in children with brain tumors and sarcomas at the end of life. Pediatr. Hematol. Oncol. 24, 409–415 (2007).
pubmed: 17710658
Schiessl, C., Gravou, C., Zernikow, B., Sittl, R. & Griessinger, N. Use of patient-controlled analgesia for pain control in dying children. Support Care Cancer 16, 531–536 (2008).
pubmed: 18274785
Ullrich, C. et al. End-of-life experience of children undergoing hematopoietic stem-cell transplantation: parent and provider perspectives and patterns of care. J. Pain Symptom Manage. 39, 331–332 (2010).
Urtubia, B. F., Bravo, A. T., Rodríguez Zamora, N., Torres, C. P. & Barria, L. C. Uso de opiáceos en niños con cáncer avanzado en cuidados paliativos. Rev. Chil. Pediatr. 87, 96–101 (2016).
Dickens, D. S. Comparing pediatric deaths with and without hospice support. Pediatr. Blood Cancer 54, 746–750 (2010).
pubmed: 20063424
Rodríguez Zamora, N., Palacios, L. D. & Bull, M. C. Programa Nacional de Cuidado Paliativo para niños con cáncer avanzado en Chile. Revisión Med. Paliat. 21, 15–20 (2014).
Davies, D., Devlaming, D. & Haines, C. Methadone analgesia for children with advanced cancer. Pediatr. Blood Cancer 51, 393–397 (2008).
pubmed: 18428431
Bosch-Alcaraz, A. La ventilación no invasiva mejora el confort al paciente paliativo pediátrico. Enfermería Intensiv. 25, 91–99 (2014).
Varma, S., Friedman, D. L. & Stavas, M. J. The role of radiation therapy in palliative care of children with advanced cancer: clinical outcomes and patterns of care. Pediatr. Blood Cancer 64, 1–7 (2016).
Flerlage, J. E. & Baker, J. N. Methylnaltrexone for opioid-induced constipation in children and adolescents and young adults with progressive incurable cancer at the end of life. J. Palliat. Med. 18, 631–633 (2015).
pubmed: 25927665
pmcid: 4492591
Anghelescu, D. L., Faughnan, L. G., Baker, J. N., Yang, J. & Kane, J. R. Use of epidural and peripheral nerve blocks at the end of life in children and young adults with cancer: the collaboration between a pain service and a palliative care service. Paediatr. Anaesth. 20, 1070–1077 (2010).
pubmed: 21199115
pmcid: 4403725
Anghelescu, D. L., Hamilton, H., Faughnan, L. G., Johnson, L.-M. & Baker, J. N. Pediatric palliative sedation therapy with propofol: recommendations based on experience in children with terminal cancer. J. Palliat. Med. 15, 1082–1090 (2012).
pubmed: 22731512
pmcid: 3438821
Breen, M. An evaluation of two subcutaneous infusion devices in children receiving palliative care. Paediatr. Care 18, 38–40 (2013).
Siden, H. & Nalewajek, G. High dose opioids in pediatric palliative care. J. Pain Symptom Manage. 25, 397–399 (2003).
pubmed: 12727032
Saad, R. et al. Bereaved parental evaluation of the quality of a palliative care program in Lebanon. Pediatr. Blood Cancer 57, 310–316 (2011).
Schmidt, P. et al. Did increased availability of pediatric palliative care lead to improved palliative care outcomes in children with cancer? J. Palliat. Med. 16, 1034–1039 (2013).
pubmed: 23901834
Wolfe, J. et al. Easing of suffering in children with cancer at the end of life: is care changing? J. Clin. Oncol. 26, 1717–1723 (2008).
pubmed: 18375901
McCluggage, H.-L. & Elborn, J. S. Symptoms suffered by life-limited children that cause anxiety to UK children’s hospice staff. Int. J. Palliat. Nurs. 12, 254–258 (2014).
Jalmsell, L. Symptoms affecting children with malignancies during the last month of life: a nationwide follow-up. Pediatrics 117, 1314–1320 (2006).
pubmed: 16585329
Hechler, T. et al. Parents’ perspective on symptoms, quality of life, characteristics of death and end-of-life decisions for children dying from cancer. Klin. Padiatr. 220, 166–174 (2008).
pubmed: 18478489
Erdman, K. & Hertel, S. Self-regulation and co-regulation in early childhood—development, assessment and supporting factors. Metacogn. Learn. 14, 229–238 (2019).
Hung, Y. N. et al. Receipt of life-sustaining treatments for taiwanese pediatric patients who died of cancer in 2001 to 2010 a retrospective cohort study. Medicine (U.S.) 95, 1–8 (2016).
Prigerson, H. G. et al. Chemotherapy use, performance status, and quality of life at the end of life. JAMA Oncol. 1, 778–784 (2015).
pubmed: 26203912
pmcid: 4828728
Lafond, D. A., Kelly, K. P., Hinds, P. S., Sill, A. & Michael, M. Establishing feasibility of early palliative care consultation in pediatric hematopoietic stem cell transplantation. J. Pediatr. Oncol. Nurs. 32, 265–277 (2015).
pubmed: 25616372
Drew, D., Goodenough, B., Maurice, L., Foreman, T. & Willis, L. Parental grieving after a child dies from cancer: is stress from stem cell transplant a factor? Int. J. Palliat. Nurs. 11, 266–273 (2014).
Tang, S. T. et al. Aggressive end-of-life care significantly influenced propensity for hospice enrollment within the last three days of life for Taiwanese cancer decedents. J. Pain. Symptom Manag. 41, 68–78 (2011).
Tomlinson, D. et al. Chemotherapy versus supportive care alone in pediatric palliative care for cancer: comparing the preferences of parents and health care professionals. CMAJ 183, E1252–E1258 (2011).
pubmed: 22007121
pmcid: 3225448
DeCourcey, D. D., Silverman, M., Oladunjoye, A., Balkin, E. M. & Wolfe J. Patterns of care at the end of life for children and young adults with life-threatening complex chronic conditions. J. Pediatr. https://doi.org/10.1016/j.jpeds.2017.09.078 (2017).
Price, J. E., Jordan, J., Prior, L. & Parkes, J. Comparing the needs of families of children dying from malignant and non-malignant disease: an in-depth qualitative study. BMJ Support Palliat. Care 2, 127–132 (2012).
pubmed: 24654053
Wolfe, J. Symptoms and suffering at the end of life in children with cancer. N. Engl. J. Med 342, 326–333 (2000).
pubmed: 10655532
Namisango, E., Bristowe, K., Allsop, M. J., Murtagh, F. E. M. & Abas, M. Symptoms and Concerns Among Children and Young People with Life‑Limiting and Life‑Threatening Conditions: A Systematic Review Highlighting Meaningful Health Outcomes (Springer International Publishing, 2018).
Danielle Cataudella. Development of a quality of life instrument for children with advanced cancer: the Pediatric Advanced Care Quality of Life Scale (PAC-QoL). Pediatr. Blood Cancer 61, 1840–1845 (2014).
pubmed: 24947134
Leahy, A. B., Feudtner, C. & Basch, E. Symptom monitoring in pediatric oncology using patient-reported outcomes: why, how, and where next. Patient 11, 147–153 (2018).
pubmed: 29071524
pmcid: 5845473
Bevans, K. & Moon, J. Patient reported outcomes as indicators of pediatric health care quality. Acad Pediatr. 14 (2014).
Hinds, P. et al. PROMIS Pediatric Measures in Pediatric Oncology: valid and clinically feasible indicators of patient-reported outcomes. Pediatr. Blood Cancer 60, 402–408 (2008).
Varni, J. W. & Burwinkle, T. M. The PedsQL